Active, not recruitingPhase 2NCT03079999

Study of Aspirin in Patients With Vestibular Schwannoma

Studying Vestibular schwannoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts Eye and Ear Infirmary
Principal Investigator
Konstantina Stankovic, MD, PhD
Stanford University
Intervention
Aspirin(drug)
Enrollment
97 enrolled
Eligibility
12 years · All sexes
Timeline
20182029

Study locations (5)

Collaborators

United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03079999 on ClinicalTrials.gov

Other trials for Vestibular schwannoma

Additional recruiting or active studies for the same condition.

See all trials for Vestibular schwannoma

← Back to all trials